US 11,793,912 B2
Cross-linked fatty acid-based biomaterials
Keith M. Faucher, Milford, NH (US); Hui Tang, Acton, MA (US); Paul Martakos, Pelham, NH (US); Theodore Karwoski, Moultonborough, NH (US); Alison Sullivan, Acton, MA (US); Greg Melville, Hudson, NH (US); and Scott E. Corbeil, Litchfield, NH (US)
Assigned to ATRIUM MEDICAL CORPORATION, Merrimack, NH (US)
Filed by ATRIUM MEDICAL CORPORATION, Merrimack, NH (US)
Filed on Oct. 8, 2020, as Appl. No. 17/66,466.
Application 17/066,466 is a division of application No. 15/794,086, filed on Oct. 26, 2017, granted, now 10,814,043.
Application 15/794,086 is a division of application No. 14/679,368, filed on Apr. 6, 2015, granted, now 9,827,352, issued on Nov. 28, 2017.
Application 14/679,368 is a continuation of application No. 12/364,763, filed on Feb. 3, 2009, granted, now 9,000,040, issued on Apr. 7, 2015.
Application 12/364,763 is a continuation in part of application No. 11/582,135, filed on Oct. 16, 2006, granted, now 8,124,127, issued on Feb. 28, 2012.
Application 12/364,763 is a continuation in part of application No. 11/236,908, filed on Sep. 28, 2005.
Application 11/236,908 is a continuation in part of application No. 11/237,264, filed on Sep. 28, 2005, granted, now 8,795,703, issued on Aug. 5, 2014.
Claims priority of provisional application 61/104,575, filed on Oct. 10, 2008.
Claims priority of provisional application 61/104,568, filed on Oct. 10, 2008.
Claims priority of provisional application 60/727,312, filed on Oct. 15, 2005.
Claims priority of provisional application 60/613,745, filed on Sep. 28, 2004.
Claims priority of provisional application 60/613,808, filed on Sep. 28, 2004.
Prior Publication US 2021/0030928 A1, Feb. 4, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 31/08 (2006.01); A61L 31/16 (2006.01); A61K 31/4353 (2006.01); A61L 31/14 (2006.01); A61F 2/82 (2013.01)
CPC A61L 31/08 (2013.01) [A61K 31/4353 (2013.01); A61L 31/148 (2013.01); A61L 31/16 (2013.01); A61F 2/82 (2013.01); A61F 2250/0067 (2013.01); A61L 2300/404 (2013.01); A61L 2300/606 (2013.01); A61L 2420/06 (2013.01); A61L 2430/00 (2013.01)] 20 Claims
 
1. A coating for a medical device obtainable by curing fatty acid based material, wherein the fatty acid based material is an oil, and adding a therapeutic agent comprising sirolimus, wherein the fatty acid was partially cross-linked before association with the therapeutic agent forming a precured material, additionally curing the fatty acid based material after addition of the therapeutic agent.